LIPOSCIENCE INC
Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | |
|---|---|---|
| Revenue | — | — |
| Operating income | −$2.3M | $1.5M |
| Net income | −$2.8M | $1.3M |
| Total assets | $72.0M | $47.7M |
| Total liabilities | $24.2M | $29.9M |
| Equity | $47.8M | −$39.6M |
| EPS (diluted) | $-0.19 | $0.13 |
| Shares out. | 15.2M | 1.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- —
- Net margin
- —
- Return on equity
- −6.0%
- Return on assets
- −4.0%
- Return on capital (ROCE)
- −4.6%
- Liabilities / assets
- 33.7%
- Debt / equity
- 0.51×
- Book value / share
- $3.14
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −324.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Altman Z″ (distress)
- 2.30grey zone
- Accruals / assets
- 10.2%high accruals
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 warning● 1 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Altman Z″ in the grey zone
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Zakrzewski Joseph SDirector | Nov 20, 2014 | D | 25,372 | $5.25 |
| Young Roderick ADirector | Nov 20, 2014 | D | 10,077 | $5.25 |
| Twiddy KathrynOfficer — VP, General Counsel, Secretary | Nov 20, 2014 | D | 27,500 | $5.25 |
| Otvos James D.Officer — EVP, Chief Scientific Officer | Nov 20, 2014 | D | 504,771 | $5.25 |
| Mcdonald E. DuffyOfficer — Vice President, HR | Nov 20, 2014 | D | 23,765 | $5.25 |
| Martindale Lucy G.Officer — EVP and CFO | Nov 20, 2014 | D | 107,881 | $5.25 |
| Levangie Daniel JDirector | Nov 20, 2014 | D | 10,077 | $5.25 |
| Hurley James RDirector | Nov 20, 2014 | D | 12,670 | $5.25 |
| Hilldale Philip DOfficer — Vice President of Sales | Nov 20, 2014 | Grant | 60,000 | $0.00 |
| Greczyn Robert J JrDirector | Nov 20, 2014 | D | 18,046 | $5.25 |
| Doran Howard JrOfficer — President and CEO | Nov 20, 2014 | D | 52,884 | $5.25 |
| Cromwell William COfficer — Chief Medical Officer | Nov 20, 2014 | D | 21,456 | $5.25 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Other material eventNov 21, 2014
- Results of operationsNov 12, 2014
- Entered a material agreement · Director / officer change · Other material eventSep 25, 2014
- Results of operationsAug 12, 2014
- Shareholder voteJun 12, 2014
- Results of operationsMay 12, 2014
- Costs from exit or disposal · Director / officer changeMay 5, 2014
- Director / officer changeMar 14, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 17, 2015
- SC 13G/AFeb 17, 2015
- SC 13GSCHEDULE 13GFeb 12, 2015
- SC 13G/AFeb 12, 2015
- 15-12BFORM 15Dec 2, 2014
- EFFECTNov 26, 2014
- 8-K/AFORM 8-K AMENDMENT NO. 1Nov 25, 2014
- S-8 POSNov 24, 2014
- S-8 POSNov 24, 2014
- POS AMNov 24, 2014
- SC 13D/ANov 24, 2014
- 4PRIMARY DOCUMENTNov 24, 2014
- 4PRIMARY DOCUMENTNov 24, 2014
- 4PRIMARY DOCUMENTNov 24, 2014
- 4PRIMARY DOCUMENTNov 24, 2014
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.